Advertisement

The Scientist

» drug development, microbiology and evolution

Most Recent

image: Opinion: Life’s X Factor

Opinion: Life’s X Factor

By | August 4, 2015

Did endosymbiosis—and the innovations in membrane bioenergetics it engendered—make it possible for eukaryotic life to evolve?

1 Comment

image: Subway Microbiome Study Revised

Subway Microbiome Study Revised

By | August 4, 2015

Researchers tone down their highly publicized study that reported the presence of deadly pathogens on New York City subways.

0 Comments

image: TB Traces

TB Traces

By | August 1, 2015

Take a trip to the mummy museum in Vác, Hungary, to see the human remains that helped researchers learn more about the origins of tuberculosis in Europe.

0 Comments

image: Anthrax Sent in Error to 86 Labs

Anthrax Sent in Error to 86 Labs

By | July 29, 2015

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: Four-legged Snake Fossil Found

Four-legged Snake Fossil Found

By | July 27, 2015

Researchers discover an unprecedented paleontological relic that may just rewrite the book on snake evolution.

3 Comments

image: Warming Climate Hurt Megafauna?

Warming Climate Hurt Megafauna?

By | July 27, 2015

The massive mammals that roamed Earth some 30,000 years ago may have gone extinct as a result of global warming, according to an ancient-DNA study.

1 Comment

image: Antibiotic Resistance Can Boost Bacterial Fitness

Antibiotic Resistance Can Boost Bacterial Fitness

By | July 22, 2015

In some pathogenic bacteria, certain antibiotic resistance–associated mutations may also confer an unexpected growth advantage.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  3. Mitochondria Exchange
    News Analysis Mitochondria Exchange

    A decade of research on intercellular mitochondrial transfer has answered some long-standing questions and raised new ones.

  4. Opinion: Engineering the Epigenome
Advertisement
Bina
Bina
Advertisement